Early Ambulation to Reduce Hospital Length of Stay
- Conditions
- AmbulationWearable Devices
- Interventions
- Device: Wearable Pedometer
- Registration Number
- NCT04444453
- Lead Sponsor
- University of Florida
- Brief Summary
Early ambulation of inpatients has been shown to be a key driver of decreased LOS and also reduced adverse events such as venous thromboembolism (VTE). We will test if a patient wearable device (pedometer) measuring steps and ambulation sessions decreases hospital LOS (primary outcome), decreases hospital LOS index (LOSI), decreases time to first ambulation, decreases time to first bowel movement (BM), decreases incidence of VTEs, and decreases costs (secondary outcomes). In a pilot randomized control trial, we will randomize 150 total adult patients admitted to UF Health Jacksonville in a 1:1 fashion to usual care and wearable pedometer or usual care. Patients randomized to the study intervention will receive a wearable pedometer upon admission, to be worn for the duration of their inpatient stay. Study outcome measures to be compared between the pedometer and no pedometer group include hospital LOS (primary outcome), hospital LOSI, time to first ambulation, time to first BM, incidence of VTEs, patient experience, and costs (secondary outcomes).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 38
- Patients ages > or equal to 18 years
- Patient has capacity to undergo informed consent
- Admitted to UF Health Jacksonville 8N progressive inpatient unit
- Inpatient physician orders for patient ambulation and/or activity as tolerated upon hospital admission
- Patient with a Fall Predictive Analytics score category of "low risk"
- Patient with a Morse Fall Scale (MFS) of < or equal to 50
- No contraindications to wearing a wrist pedometer (no skin breakdown, overlying skin infections, contact dermatitis, or indwelling catheters/need for venipuncture at wrist site)
- Patient < 18 years of age
- Patient without capacity to undergo informed consent
- Patient with a 'do not ambulate' order or has order for bed rest or other contraindication to ambulation (i.e., fall risk) or dependent on more than minimal assistance to ambulate
- Patient with a Fall Predictive Analytics score category of "high risk"
- Patient with MFS > 50 or labelled by clinical team as fall risk
- Non-English speaking
- In law enforcement custody or ward of the state
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pedometer Wearable Pedometer Admitted patients who receive a pedometer to wear during their hospital stay to measure steps ambulated
- Primary Outcome Measures
Name Time Method Hospital Length of Stay Up to 1 month Time patient is admitted in hospital
- Secondary Outcome Measures
Name Time Method Time to first bowel movement Up to 1 month Hospital length-of-stay index Up to 1 month Time to first ambulation Up to 1 month Rate of venous thromboembolism Up to 1 month Total hospitalization costs Up to 1 month
Trial Locations
- Locations (1)
University of Florida
🇺🇸Jacksonville, Florida, United States